PubMed · 1991 · 60 citations · 0 references
MedicineCardiologyOncologyCardio-oncologyChemotherapyMedical OncologyAdverse Effects Of ChemotherapyAnthracycline CardiotoxicityCancer Therapy-related CardiotoxicityCardiotoxicity ManagementChemotherapy Toxicity ManagementPediatric Cardio-oncologyAnthracycline-based ChemotherapyAnthracycline-induced CardiotoxicityAnthracycline-related Heart FailureChildhood Cancer IncidenceDoxorubicin CardiotoxicityLong-term Cardiac Follow-upPediatric Anthracycline CardiotoxicitySurvivorship Cardio-oncology
Survivors of childhood cancer who received anthracycline treatment have a high incidence of abnormal cardiac function. Cardiac decompensation and death can appear many years after completion of chemotherapy. These survivors require periodic evaluation of cardiac function and rhythm.